Here is a list of stocks with an above 10% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. Genmab A/S

50.9% sales growth and 36.46% return on equity

Genmab A/S, a biotechnology company, develops antibody therapeutics for the treatment of cancer primarily in Denmark.

Genmab A/S’s sales growth this year is expected to be 102.3% and a negative 20.7% for next year.

Year-on-year quarterly revenue growth grew by 65.8%, now sitting on N/A for the twelve trailing months.

Genmab A/S’s sales growth for the next quarter is 50.9%. The company’s growth estimates for the ongoing quarter and the next is a negative 64.2% and 30%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 36.46%.

Volatility

Genmab A/S’s last day, last week, and last month’s average volatility was 4.13%, 1.25%, and 0.44%, respectively.

Genmab A/S’s last day, last week, and last month’s high and low average amplitude percentage was 3.30%, 1.98%, and 1.80%, respectively.

Genmab A/S’s Stock Yearly Top and Bottom Value

Genmab A/S’s stock is valued at $42.83 at 16:22 EST, way under its 52-week low of $16.24.

Genmab A/S’s Moving Average

Genmab A/S’s worth is higher than its 50-day moving average of $39.36 and way above its 200-day moving average of $36.95.

Previous days news about Genmab A/S

According to Business Insider on Friday, 15 January, "About DARZALEXFASPRO® In August 2012, Janssen Biotech, Inc. and Genmab A/S entered into a worldwide agreement, which granted Janssen an exclusive license to develop, manufacture and commercialize daratumumab. "

2. DouYu International Holdings Limited

32.3% sales growth and 10.7% return on equity

DouYu International Holdings Limited operates a platform on PC and mobile apps that provides interactive games and entertainment live streaming in China.

DouYu International Holdings Limited’s sales growth this year is expected to be 47.1% and 21.2% for next year.

Year-on-year quarterly revenue growth grew by 37%, now sitting on N/A for the twelve trailing months.

DouYu International Holdings Limited’s sales growth for the next quarter is 32.3%. The company’s growth estimates for the present quarter and the next is a negative 0% and 7.1%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.7%.

Volatility

DouYu International Holdings Limited’s last day, last week, and last month’s average volatility was a positive 0.34%, a negative 0.21%, and a negative 0.21%, respectively.

DouYu International Holdings Limited’s last day, last week, and last month’s high and low average amplitude percentage was 2.78%, 4.70%, and 4.48%, respectively.

DouYu International Holdings Limited’s Stock Yearly Top and Bottom Value

DouYu International Holdings Limited’s stock is valued at $12.14 at 16:22 EST, way under its 52-week high of $17.85 and way above its 52-week low of $6.11.

DouYu International Holdings Limited’s Moving Average

DouYu International Holdings Limited’s worth is higher than its 50-day moving average of $12.01 and way under its 200-day moving average of $13.79.

3. Encore Capital Group Inc

29.5% sales growth and 21.31% return on equity

Encore Capital Group, Inc., a specialty finance company, together with its subsidiaries, provides debt recovery solutions and other related services for consumers across a range of financial assets worldwide.

Encore Capital Group Inc’s sales growth this year is anticipated to be 6.9% and 1.6% for next year.

Year-on-year quarterly revenue growth grew by 16.2%, now sitting on 1.49B for the twelve trailing months.

Encore Capital Group Inc’s sales growth for the next quarter is 29.5%. The company’s growth estimates for the ongoing quarter and the next is 36.5% and 1221.1%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 21.31%.

Volatility

Encore Capital Group Inc’s last day, last week, and last month’s average volatility was a negative 7.97%, a negative 3.03%, and a negative 0.67%, respectively.

Encore Capital Group Inc’s last day, last week, and last month’s high and low average amplitude percentage was 10.95%, 7.17%, and 5.12%, respectively.

Encore Capital Group Inc’s Stock Yearly Top and Bottom Value

Encore Capital Group Inc’s stock is valued at $33.63 at 16:22 EST, way below its 52-week high of $49.01 and way higher than its 52-week low of $15.27.

Encore Capital Group Inc’s Moving Average

Encore Capital Group Inc’s worth is under its 50-day moving average of $37.21 and way below its 200-day moving average of $37.92.

4. Laboratory Corporation of America Holdings

28.4% sales growth and 10.9% return on equity

Laboratory Corporation of America Holdings operates as an independent clinical laboratory company worldwide.

Laboratory Corporation of America Holdings’s sales growth this year is expected to be 16.3% and 3.7% for next year.

Year-on-year quarterly revenue growth grew by 33%, now sitting on 12.44B for the twelve trailing months.

Laboratory Corporation of America Holdings’s sales growth for the next quarter is 28.4%. The company’s growth estimates for the ongoing quarter and the next is 155.9% and 141.4%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.9%.

Volatility

Laboratory Corporation of America Holdings’s last day, last week, and last month’s average volatility was a negative 2.22%, a positive 0.97%, and a positive 0.27%, respectively.

Laboratory Corporation of America Holdings’s last day, last week, and last month’s high and low average amplitude percentage was 4.29%, 3.19%, and 2.09%, respectively.

Laboratory Corporation of America Holdings’s Stock Yearly Top and Bottom Value

Laboratory Corporation of America Holdings’s stock is valued at $213.55 at 16:22 EST, under its 52-week high of $220.35 and way higher than its 52-week low of $98.02.

Laboratory Corporation of America Holdings’s Moving Average

Laboratory Corporation of America Holdings’s worth is above its 50-day moving average of $203.00 and way above its 200-day moving average of $191.79.

Previous days news about Laboratory Corporation of America Holdings

According to Business Insider on Monday, 11 January, "The key players operating in the global contract research organizations market are IQVIA Holdings Inc. (U.S.), Laboratory Corporation of America Holdings (U.S.), Charles River Laboratories International, Inc. (U.S.), Wuxi Apptec Co., Ltd. "

5. Installed Building Products, Inc.

14.7% sales growth and 33.33% return on equity

Installed Building Products, Inc., together with its subsidiaries, engages in the installation of insulation, waterproofing, fire-stopping, fireproofing, garage doors, rain gutters, window blinds, shower doors, closet shelving and mirrors, and other products in the continental United States.

Installed Building Products, Inc.’s sales growth this year is expected to be 9.7% and 15.4% for next year.

Year-on-year quarterly revenue growth grew by 6.1%, now sitting on 1.61B for the twelve trailing months.

Installed Building Products, Inc.’s sales growth for the next quarter is 14.7%. The company’s growth estimates for the present quarter and the next is 33.7% and 39.7%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 33.33%.

Volatility

Installed Building Products, Inc.’s last day, last week, and last month’s average volatility was a negative 5.91%, a positive 0.89%, and a positive 0.68%, respectively.

Installed Building Products, Inc.’s last day, last week, and last month’s high and low average amplitude percentage was 6.95%, 5.35%, and 4.00%, respectively.

Installed Building Products, Inc.’s Stock Yearly Top and Bottom Value

Installed Building Products, Inc.’s stock is valued at $106.59 at 16:22 EST, way under its 52-week high of $121.67 and way higher than its 52-week low of $29.02.

Installed Building Products, Inc.’s Moving Average

Installed Building Products, Inc.’s worth is above its 50-day moving average of $101.38 and way higher than its 200-day moving average of $93.00.

6. Afya Limited

39% sales growth and 12.45% return on equity

Afya Limited, through its subsidiaries, operates as a medical education group in Brazil.

Afya Limited’s sales growth this year is expected to be 54.9% and 37.1% for next year.

Year-on-year quarterly revenue growth grew by 49.7%, now sitting on N/A for the twelve trailing months.

Afya Limited’s sales growth for the next quarter is 39%. The company’s growth estimates for the present quarter and the next is 38.1% and 7.7%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.45%.

Volatility

Afya Limited’s last day, last week, and last month’s average volatility was a negative 0.61%, a negative 0.38%, and a negative 0.01%, respectively.

Afya Limited’s last day, last week, and last month’s high and low average amplitude percentage was 2.99%, 4.06%, and 4.42%, respectively.

Afya Limited’s Stock Yearly Top and Bottom Value

Afya Limited’s stock is valued at $24.47 at 16:22 EST, way under its 52-week high of $30.98 and way above its 52-week low of $13.98.

Afya Limited’s Moving Average

Afya Limited’s value is under its 50-day moving average of $25.08 and under its 200-day moving average of $25.35.

7. PulteGroup, Inc.

23.3% sales growth and 22.84% return on equity

PulteGroup, Inc., through its subsidiaries, primarily engages in the homebuilding business in the United States.

PulteGroup, Inc.’s sales growth this year is anticipated to be 7% and 19.9% for next year.

Year-on-year quarterly revenue growth grew by 9%, now sitting on 10.86B for the twelve trailing months.

PulteGroup, Inc.’s sales growth for the next quarter is 23.3%. The company’s growth estimates for the ongoing quarter and the next is 13.1% and 45.9%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 22.84%.

Volatility

PulteGroup, Inc.’s last day, last week, and last month’s average volatility was a negative 2.31%, a negative 0.76%, and a negative 0.06%, respectively.

PulteGroup, Inc.’s last day, last week, and last month’s high and low average amplitude percentage was 4.33%, 4.23%, and 3.04%, respectively.

PulteGroup, Inc.’s Stock Yearly Top and Bottom Value

PulteGroup, Inc.’s stock is valued at $41.53 at 16:22 EST, way below its 52-week high of $49.70 and way higher than its 52-week low of $17.12.

PulteGroup, Inc.’s Moving Average

PulteGroup, Inc.’s worth is below its 50-day moving average of $43.26 and below its 200-day moving average of $43.04.

8. NVIDIA

50.1% sales growth and 28.82% return on equity

NVIDIA Corporation operates as a visual computing company worldwide.

NVIDIA’s sales growth this year is expected to be 51% and 20.6% for next year.

Year-on-year quarterly revenue growth grew by 56.8%, now sitting on 14.78B for the twelve trailing months.

NVIDIA’s sales growth for the next quarter is 50.1%. The company’s growth estimates for the ongoing quarter and the next is 48.1% and 40%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 28.82%.

Volatility

NVIDIA’s last day, last week, and last month’s average volatility was a negative 2.51%, a negative 0.22%, and a negative 0.04%, respectively.

NVIDIA’s last day, last week, and last month’s high and low average amplitude percentage was 3.18%, 3.09%, and 2.75%, respectively.

NVIDIA’s Stock Yearly Top and Bottom Value

NVIDIA’s stock is valued at $514.38 at 16:22 EST, way under its 52-week high of $589.07 and way higher than its 52-week low of $180.68.

NVIDIA’s Moving Average

NVIDIA’s value is under its 50-day moving average of $529.94 and higher than its 200-day moving average of $500.67.

Previous days news about NVIDIA

According to Business Insider on Monday, 11 January, "MAGNUS ONE is equipped with the ZOTAC GAMING GeForce RTX 3070 desktop graphics card powered by the NVIDIA Ampere architecture, the 2nd generation of NVIDIA GeForce RTX. "

According to Business Insider on Tuesday, 12 January, "Cloud Growth Continues: Arya said he continues to like NVIDIA Corporation (NASDAQ:NVDA) and Advanced Micro Devices, Inc. (NASDAQ:AMD). "

According to Business Insider on Thursday, 14 January, "The touchscreens on those models are powered by an NVIDIA processor which stores data in an attached "flash memory device." But those devices have a finite amount of storage capacity, and according to the NHTSA’s investigation, once they filled up – which happened after just 5 to 6 years, on average – they shut down, causing the MCUs to fail and creating other safety issues."

LEAVE A REPLY

Please enter your comment!
Please enter your name here